Orange Book product
SUMATRIPTAN AND NAPROXEN SODIUM 500MG;EQ 85MG BASE
Orange Book ANDA 090872 · RISING PHARMA HOLDINGS INC · Prescription
Key facts
| Proprietary name | SUMATRIPTAN AND NAPROXEN SODIUM |
|---|---|
| Active ingredients | NAPROXEN SODIUM, SUMATRIPTAN SUCCINATE |
| Strength | 500MG;EQ 85MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Application | ANDA090872 |
| Applicant holder | RISING PHARMA HOLDINGS INC |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AB |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Sep 4, 2018 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.